Connection
Jacob Houghton to Radioimmunotherapy
This is a "connection" page, showing publications Jacob Houghton has written about Radioimmunotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.216 |
|
|
|
-
Jallinoja VIJ, Houghton JL. Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy. J Nucl Med. 2021 Sep 01; 62(9):1200-1206.
Score: 0.681
-
Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry. Mol Cancer Ther. 2017 01; 16(1):124-133.
Score: 0.497
-
Escorcia FE, Houghton JL, Abdel-Atti D, Pereira PR, Cho A, Gutsche NT, Baidoo KE, Lewis JS. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Theranostics. 2020; 10(1):151-165.
Score: 0.039